Modular Medical, Inc. (MODD) has a 5-year average return on invested capital (ROIC) of -74.3%. This is below average and may indicate limited pricing power.
Modular Medical, Inc. (MODD) has a market capitalization of $195M. It is classified as a small-cap stock.
Modular Medical, Inc. (MODD) does not currently pay a regular dividend.
Modular Medical, Inc. (MODD) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
Modular Medical, Inc. (MODD) generated $-10 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Modular Medical, Inc. (MODD) has a debt-to-equity ratio of 0.11. This indicates a conservatively financed balance sheet.
Modular Medical, Inc. (MODD) reported earnings per share (EPS) of $-0.69 in its most recent fiscal year.
We are a pre-revenue, medical device company focused on the design, development, and commercialization of innovative insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. Through the creation of an innovative two-part patch pump, we seek to fundamentally alter the trade-offs between cost and complexity and access to the higher standards of care that presently require considerable motivation from the patient to use the available insulin pumps. By simplifying and streamlining the user experience from the initial introduction of the patient to our product, prescription assistance, establishing insurance reimbursement, streamlined training and day-to-day use with strong clinical support, we seek to expand the wearable insulin delivery device market beyond the highly motivated “super users” to expand the category into the mass market.
| Metric | TTM | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Revenue | 0 | - | - | - | - | 0 |
| Net Income | -27M | -19M | -7.4M | -5.3M | -2.5M | -659K |
| EPS | $-0.44 | $-0.69 | $-0.30 | $-0.23 | $-0.11 | $-0.04 |
| Free Cash Flow | -26M | -10M | -6.0M | -4.4M | -1.9M | -806K |
| ROIC | -720.6% | -133.4% | -927.1% | -109.5% | -38.7% | -15.4% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.11 | -2.64 | 0.00 | - | - |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -27M | -15M | -7.3M | -5.3M | -2.6M | -666K |
| Operating Margin | 0.0% | - | - | - | - | - |
| ROE | -455.3% | -492.8% | - | -113.8% | - | - |
| Shares Outstanding | 78M | 27M | 25M | 24M | 23M | 18M |
| Metric | 2011 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | N/A | N/A | N/A | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | 0 | 333K | 1.9M | 3.0M | 4.1M | 7.7M | 20M |
| SG&A | 9K | 10K | 11K | 11K | 16K | 13K | 12K | 99K | 695K | 2.3M | 3.3M | 7.2M | 6.8M |
| EBIT | -9K | -10K | -11K | -11K | -16K | -13K | -29K | -666K | -2.6M | -5.3M | -7.3M | -15M | -27M |
| Op. Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Net Income | N/A | -17K | -21K | -23K | -31K | -31K | -107K | -659K | -2.5M | -5.3M | -7.4M | -19M | -27M |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | N/A | N/A | N/A | N/A | N/M | -2.7% | -8.1% | -15.4% | -38.7% | -109.5% | N/M | -133.4% | N/M |
| ROE | N/A | 22.0% | N/A | N/A | N/A | -28.6% | -28.7% | N/A | N/A | -113.8% | N/A | -492.8% | -455.3% |
| ROA | N/A | N/A | N/A | N/A | -1239.8% | N/A | -27.2% | -27.9% | -46.2% | -101.2% | -241.6% | -308.1% | -261.0% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 0 | 0 | 0 | 0 | 0 | -11K | -95K | -791K | -1.8M | -4.1M | -5.9M | -10M | -22M |
| Free Cash Flow | 0 | 0 | 0 | 0 | 0 | -11K | -95K | -806K | -1.9M | -4.4M | -6.0M | -10M | -26M |
| Owner Earnings | 0 | 0 | 0 | 0 | 0 | -11K | -95K | -793K | -2.4M | -4.9M | -7.3M | -15M | -28M |
| CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15K | 77K | 261K | 110K | 55K | 3.9M |
| Maint. CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 16K | 52K | 152K | 250K | 3.1M |
| Growth CapEx | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 13K | 61K | 209K | 0 | 0 | 802K |
| D&A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 16K | 52K | 152K | 250K | 3.1M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 188K | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0 | 532K | 801K | 1.2M | 4.0M | 2.4M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -3.1M | 1.9M | N/A | -2.9M |
| Cash & Equiv. | N/A | 0 | N/A | N/A | 0 | 390K | 392K | 4.3M | 6.6M | 3.1M | 1.5M | 9.1M | 2.9M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | N/A | -1.00 | N/A | -1.00 | -1.02 | 0.51 | 0.08 | N/A | N/A | 0.00 | -2.64 | 0.11 | 0.00 |
| Interest Coverage | N/A | -1.2 | -1.1 | -0.9 | -1.1 | -0.7 | -1.9 | -78.2 | -65.4 | N/A | -184.4 | -5.4 | -5.4 |
| Equity | N/A | -88K | N/A | -132K | -163K | 380K | 363K | N/A | N/A | 2.9M | -1.3M | 8.8M | 5.9M |
| Total Assets | N/A | 0 | N/A | 0 | 3K | 0 | 392K | 4.3M | 6.7M | 3.9M | 2.2M | 9.8M | 10M |
| Total Liabilities | N/A | 88K | 109K | 132K | 165K | 194K | 30K | N/A | N/A | 980K | 3.5M | 1.0M | 4.4M |
| Intangibles | N/A | N/A | N/A | N/A | N/A | N/A | 0 | 0 | 0 | 0 | N/A | N/A | N/A |
| Retained Earnings | N/A | N/A | N/A | -216K | -247K | -278K | -49K | -709K | -3.2M | -8.6M | -16M | -35M | -107M |
| Working Capital | N/A | N/A | N/A | N/A | -163K | N/A | 363K | 4.3M | 6.4M | 2.5M | -1.6M | 8.4M | 1.3M |
| Current Assets | N/A | N/A | N/A | 0 | 3K | 0 | 392K | 4.3M | 6.6M | 3.2M | 1.6M | 9.4M | 3.5M |
| Current Liabilities | N/A | 88K | 109K | 132K | 165K | 194K | 30K | 15K | 179K | 661K | 3.3M | 970K | 2.2M |
| Per Share Data | |||||||||||||
| EPS | -0.01 | -0.00 | -0.02 | -0.02 | -0.02 | -0.00 | -0.01 | -0.04 | -0.11 | -0.23 | -0.30 | -0.69 | -0.44 |
| Owner EPS | N/A | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | -0.01 | -0.04 | -0.10 | -0.21 | -0.30 | -0.53 | -0.36 |
| Book Value | N/A | -0.00 | N/A | -0.12 | -0.10 | 0.01 | 0.03 | N/A | N/A | 0.12 | -0.05 | 0.32 | 0.08 |
| Cash Flow/Share | N/A | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | -0.01 | -0.04 | -0.08 | -0.17 | -0.24 | -0.38 | -0.31 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | N/A | 35.0M | 1.0M | 1.1M | 1.5M | 31.1M | 11.8M | 17.9M | 22.6M | 23.6M | 24.6M | 27.2M | 77.7M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -5.8 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 3.2 | 33.2 |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -36.5% | -13.4% |
| Market Cap | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 28M | 195M |
| Avg. Price | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 3.86 | 2.51 |
| Year-End Price | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 4.15 | 2.51 |
Modular Medical, Inc. passes 0 of 9 quality checks, indicating weak fundamentals.
Modular Medical, Inc. (MODD) has a return on equity (ROE) of -492.8%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 12 years of financial data for Modular Medical, Inc. (MODD), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Modular Medical, Inc. (MODD) has a book value per share of $0.32, based on its most recent annual SEC filing.
No recent press releases.